EXPO (NASDAQ: EXPO) insider files Form 144 to sell 1,663 shares
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
A person associated with EXPO has filed a Form 144 notice to sell 1,663 shares of common stock through Morgan Stanley Smith Barney LLC on or around 01/15/2026 on the NASDAQ. These shares were acquired the same day by exercising stock options and paid for in cash.
The notice also lists prior Rule 10b5-1 plan sales for Catherine Corrigan in the past three months, including 3,225 shares sold on 12/15/2025 for gross proceeds of $240,171.23, and additional sales of 3,225 shares and 1,675 shares on 11/17/2025 for gross proceeds of $226,411.13 and $118,487.32, respectively.
Positive
- None.
Negative
- None.
FAQ
What does the EXPO Form 144 filing disclose?
The Form 144 filing discloses an intention to sell 1,663 shares of EXPO common stock, with the shares to be sold on or about 01/15/2026 on the NASDAQ.
What gross proceeds are reported for recent EXPO stock sales?
Reported gross proceeds include $240,171.23 for 3,225 shares sold on 12/15/2025, and $226,411.13 plus $118,487.32 for sales totaling 4,900 shares on 11/17/2025.
Is the EXPO Form 144 sale connected to a Rule 10b5-1 trading plan?
The section on sales during the past 3 months identifies them as 10b5-1 sales for Catherine Corrigan, indicating those prior transactions were made under a Rule 10b5-1 trading plan.